Tazemetostat Hydrobromide Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Mar 27, 2026 · last update Mar 27, 2026
Manufacturers: Epizyme, Inc. (An Ipsen Company)
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tazverik, Tablet, 200 mg (NDC 72607-100-00) | Epizyme, Inc. (An Ipsen Company) | To Be Discontinued | — | Discontinuation of the manufacture of the drug product | Posted Mar 27, 2026 Updated Mar 27, 2026 Discontinued Mar 27, 2026 |